Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells

Bioconjugate Chemistry

Volumn 8, Issue 3, 1997, Pages 338-346

  Cho, Bryan K ^a   Roy, Edward J ^b   Patrick, Todd A ^b   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL MEMBRANES; CHAINS; CYTOLOGY; MOLECULES; T-CELLS; TUMORS;

CYTOTOXIC T LYMPHOCYTES; FOLATE RECEPTOR; FOLATES; IMMUNE RECOGNITION; OVARIAN CARCINOMA; RECOGNITION MECHANISM; SINGLE-CHAIN FV; T CELLS RECEPTORS; TUMOR ANTIGEN; TUMOUR CELLS;

ANTIBODIES;

EID: 0031149555     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9700244     Document Type: Article

References (58)

1. Gorer, P. A. (1937) The genetic and antigenic basis of tumor transplantation. J. Pathol. Bacteriol. 44, 691-697.
2. Boon, T. (1993) Teaching the immune system to fight cancer. Sci. Am. 268, 82-89.
3. Pardoll, D. M. (1994) A new look for the 1990s. Nature 369, 357-358.
4. Klein, G., and Boon, T. (1993) Tumor immunology: present perspectives. Curr. Opin. Immunol. 5, 687-692.
5. Fanger, M. W., Morganelli, P. M., and Guyre, P. M. (1992) Bispecific antibodies. Crit. Rev. Immunol. 12, 101-124.
6. Liu, M. A., Nussbaum, S. R., and Eisen, H. N. (1988) Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells. Science 239, 395-398.
7. Nitta, T., Yagita, H., Sato, K., Okumura, K., and Ishii, S. (1990) Preliminary trials of specific targeting therapy against malignant glioma. Lancet 335, 368-371.
8. Chen, J., Zhou, J. H., Mokotoff, M., Fanger, M. W., and Ball, E. D. (1995) Lysis of small cell carcinoma of the lung (SCCL) cells by cytokine-activated monocytes and natural killer cells in the presence of bispecific immunoconjugates containin a gastrin-releasing peptide (GRP) analog or a GRP antagonist. J. Hematother. 4, 369-376.
9. Canevari, S., Miotti, S., Bottero, F., Valota, O., and Colnaghi, M. I. (1993) Ovarian carcinoma therapy with monoclonal antibodies. Hybridoma 12, 501-507.
10. Canevari, S., Stoter, G., Arienti, F., Bolis, G., Colnaghi, M. I., Di Re, E. M., Eggermont, A. M. M., Goey, S. H., Gratama, J. W., Lamers, C. H. J., Nooy, M. A., Parmiani, G., Raspagliesi, F., Ravagnani, F., Scarfone, G., Trimbos, J. B., Warnaar, S. O., and Bolhuis, R. L. H. (1995) Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. J. Natl. Cancer Inst. 87, 1463-1469.
11. Weiner, L. M., Clark, J. I., Davey, M., Li, W. S., Garcia de Palazzo, I., Ring, D. B., and Alpaugh, R. K. (1995) Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII. Cancer Res. 55, 4586-4593.
12. Lamers, C. H., Gratama, J. W., Warnaar, S. O., Stoter, G., and Bolhuis, R. L. (1995) Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes. Int. J. Cancer. 60, 450-457.
13. Buist, M. R., Molthoff, C. F. M., Kenemans, P., and Meijer, C. J. L. M. (1995) Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue. J. Clin. Pathol. 48, 631-636.
14. Ross, J. F., Chaudhuri, P. K., and Ratnam, M. (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73, 2432-2443.
15. Weitman, S. D., Frazier, K. M., and Kamen, B. A. (1994) The folate receptor in central nervous system malignancies of childhood. J. Neurooncol. 21, 107-112.
16. Knapp, R. C., and Berkowitz, R. S. (1993) Gynecologic Oncology, 250 pp, McGraw-Hill, New York.
17. Allen, J., Wisoff, J., Helson, L., Pearce, J., and Arenson, E. (1992) Choroid plexus carcinoma-responses to chemotherapy alone in newly diagnosed young children. J. Neuro-Oncol. 12, 69-74.
18. Dohrmann, G. J., Farwell, J. R., and Flannery, J. T. (1976) Ependymomas and ependymoblastomas in children. J. Neurosurg. 45, 273-283.
19. Coney, L. R., Tomassetti, A., Carayannopoulos, L., Frasca, V., Kamen, B. A., Colnaghi, M. I., and Zurawski, V. R., Jr. (1991) Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 51, 6125-6132.
20. van Ravenswaay Claasen, H. H., van de Griend, R. J., Mezzanzanica, D., Bolhuis, R. L., Warnaar, S. O., and Fleuren, G. J. (1993) Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3. Int. J. Cancer 55, 128-136.
21. Coney, L. R., Mezzanzanica, D., Sanborn, D., Casalini, P., Colnaghi, M. I., and Zurawski, V. R. (1994) Chimeric murine human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res. 54, 2448-2455.
22. Leamon, C. P., and Low, P. S. (1994) Selective targeting of malignant cells with cytotoxin-folate conjugates. J. Drug Target. 2, 101-112.
23. Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., and Low, P. S. (1995) Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Asci. U.S.A. 92, 3318-3312.
24. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., Jr., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
25. Weitman, S. D., Weinberg, A. G., Coney, L. R., Zurawski, V. R., Jennings, D. S., and Kamen, B. A. (1992) Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 52, 6708-6711.
26. Antony, A. C. (1996) Folate receptors. Annu. Rev. Nutr. 16, 501-521.
27. Kranz, D. M., Patrick, T. A., Brigle, K. E., Spinella, M. J., and Roy, E. J. (1995) Conjugates of folate and anti-T cell receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. Natl. Acad. Sci. U.S.A. 92, 9057-9061.
28. Yokota, T., Milenic, D. E., Whitlow, M., and Schlom, J. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402-3408.
29. Cho, B. K., Schodin, B. A., and Kranz, D. M. (1995) Characterization of a single-chain antibody to the β-chain of the T cell receptor. J. Biol. Chem. 270, 25819-25826.
30. Friend, C., Patuleia, M. C., and De Harven, E. (1966) Erythrocytic maturation in vitro of murine (Friend) virus-induced leukemic cells. NCI Monographs No. 22, 505-522.
31. Brigle, K. E., Spinella, M. J., Westin, E. H., and Goldman, I. D. (1994) Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem. Pharmacol. 47, 337-345.
32. Law, L. W., B, D. T., Boyle, P. J., and Miller, J. H. (1949) Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice. J. Natl. Cancer Inst. 10, 179-192.
33. Brigle, K. E., Seither, R. L., Westin, E. H., and Goldman, I. D. (1994) Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier. J. Biol. Chem. 269, 4267-4272.
34. Kranz, D. M., Sherman, D. H., Sitkovsky, M. V., Pasternack, M. S., and Eisen, H. N. (1984) Immunoprecipitation of cell surface structure of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. U.S.A. 81, 573-577.
35. Haskins, K., Hannum, C., White, J., Rhoem, N., Kubo, R., Kappler, J., and Marrack, K. (1984) The antigen-specific major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J. Exp. Med. 160, 452-471.
36. d antigen, the product of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125, 2473-2477.
37. Leamon, C. P., and Low, P. S. (1992) Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267, 24966-24971.
38. Whitlow, M., and Filpula, D. (1991) Single-chain Fv proteins and their fusion proteins. Methods: A Companion to Methods in Enzymology, Vol. 2, pp 97-105, Academic, San Diego.
39. Rojo, J. M., and Janeway, C. A., Jr. (1988) The biologic activity of anti-T cell receptor V region monoclonal antibodies is determined by the epitope recognized. J. Immunol. 140, 1081-1088.
40. Leamon, C. P., Pastan, I., and Low, P. S. (1993) Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J. Biol. Chem. 268, 24847-24854.
41. Gruber, M., Schodin, B., Wilson, E., and Kranz, D. M. (1994) Efficient tumor cell lysis mediated by a bispecific single-chain antibody expressed in E. coli. J. Immunol. 152, 5368-5374.
42. Kutsky, R. J. (1981) Handbook of Vitamins, Minerals, and Hormones, 2nd ed., 492 pp, Van Nostrand Reinhold, New York.
43. Lentner, C. (1984) Geigy Scientific Tables, 8th rev., Physical chemistry, composition of blood, hematology, somatometric data, Vol. 3, 131 pp, Ciba-Geigy Limited, Basle, Switzerland.
44. Mathias, C. J., Wang, S., Lee, R. J., Waters, D. J., Low, P. S., and Green, M. A. (1996) Tumor-selective radiopharmaceutical targeting via receptor-mediate endocytosis of gallium-67-deferoxamine-folate. J. Nucl. Med. 37, 1003-1008.
45. Gospe Jr., S. M., Gietzen, D. W., Summers, P. J., Lunetta, J. M., Miller, J. W., Selhub, J., Ellis, W. G., and Clifford, A. J. (1995) Behavioral and neurochemical changes in folate-deficient mice. Physiol. Behav. 58, 935-941.
46. Hollinger, P., Prospero, T., and Winter, G. (1993) "Diabodies": Small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. U.S.A. 90, 6444-6448.
47. Kurucz, I., Titus, J. A., Jost, C. R., Jacobus, C. M., and Segal, D. M. (1995) Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria. J. Immunol. 154, 4576-4582.
48. Winter, G., Griffiths, A. D., Hawkins, R. E., and Hoogenboom, H. R. (1994) Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.
49. Elwood, P. C., Kane, M. A., Portillo, R. M., and Kolhouse, J. F. (1986) The isolation, characterization, and comparison of the membrane-associated and soluble folate-binding proteins from human KB cells. J. Biol. Chem. 261, 15416-15423.
50. Mack, M., Riethmuller, G., and Kufer, P. (1995) A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 92, 7021-7025.
51. Zhu, Z., Zapata, G., Shalaby, R., Snedecor, B., Chen, H., and Carter, P. (1996) High level secretion of a humanized bispecific diabody from Escherichia coli. Biotechnology 14, 192-196.
52. Sugiyama, Y., Aihara, M., Shibamori, M., Deguchi, K., Imagawa, K., Kikuchi, M., Momata, H., Azuma, T., Okada, H., Alper, Ö., Hitomi, J., and Yamaguchi, K. (1992) In vitro anti-tumor activity of anti-c-erbB-2 x anti-CD3∈ bifunctional monoclonal antibody. Jpn. J. Cancer Res. 83, 563-267.
53. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. (1989) A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339, 394-397.
54. Chaudhary, V. K., Gallo, M. G., FitzGerald, D. J., and Pastan, I. (1990) A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin. Proc. Natl. Acad. Sci. U.S.A. 87, 9491-9494.
55. Burrows, F. J., and Thorpe, P. E. (1993) Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl. Acad. Sci. U.S.A. 90, 8996-9000.
56. Wels, W., Harwerth, I. M., Mueller, M., Groner, B., and Hynes, N. E. (1992) Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res. 52, 6310-6317.
57. Schodin, B. A., Tsomides, T. J., and Kranz, D. M. (1996) Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5, 137-146.
58. Patrick, T. A., Kranz, D. M., Van Dyke, T. A., and Roy, E. J. (1997) Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J. Neuro-Oncol. (in press).